TMCnet News
Research and Markets: Global Recurrent Glioblastoma Multiforme (GBM) Therapeutics Pipeline Review, H2 2015Research and Markets (http://www.researchandmarkets.com/research/s6wgb3/recurrent) has announced the addition of the "Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Recurrent Glioblastoma Multiforme (GBM), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Recurrent Glioblastoma Multiforme (GBM) and special features on late-stage and discontinued projects. The report enhances decision maing capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/s6wgb3/recurrent
View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005338/en/ |
